Sanz G - Search Results

1

Challenges of phase III trial design for novel treatments in diseases with no standard treatment: the AZA-001 myelodysplasia study model.

Fenaux P, Seymour JF, Santini V, Silverman L, Gore S, List A, Sanz G, Mufti GJ, Estey E, Swern AS, Beach CL, Hellstrom-Lindberg E. Fenaux P, et al. Among authors: sanz g. Leuk Res. 2014 Feb;38(2):258-62. doi: 10.1016/j.leukres.2013.10.014. Epub 2013 Oct 27. Leuk Res. 2014. PMID: 24360612 Free article.

2

Prognostic factors in myelodysplastic syndromes.

Sanz GF, Sanz MA. Sanz GF, et al. Among authors: sanz ma. Leuk Res. 1992;16(1):77-86. doi: 10.1016/0145-2126(92)90105-g. Leuk Res. 1992. PMID: 1732678 Review.

3

International scoring system for evaluating prognosis in myelodysplastic syndromes.

Greenberg P, Cox C, LeBeau MM, Fenaux P, Morel P, Sanz G, Sanz M, Vallespi T, Hamblin T, Oscier D, Ohyashiki K, Toyama K, Aul C, Mufti G, Bennett J. Greenberg P, et al. Among authors: sanz g, sanz m. Blood. 1997 Mar 15;89(6):2079-88. Blood. 1997. PMID: 9058730 Free article.

4

Carboplatin plus cytarabine in the treatment of high-risk acute myeloblastic leukemia.

Larrea L, Martínez JA, Sanz GF, Martín G, de la Rubia J, Jiménez C, Jarque I, Cid A, López A, Sanz MA. Larrea L, et al. Among authors: sanz ma, sanz gf. Leukemia. 1999 Feb;13(2):161-5. doi: 10.1038/sj.leu.2401278. Leukemia. 1999. PMID: 10025888

5

Problematic WHO reclassification of myelodysplastic syndromes. Members of the International MDS Study Group.

Greenberg P, Anderson J, de Witte T, Estey E, Fenaux P, Gupta P, Hamblin T, Hellstrom-Lindberg E, List A, Mufti G, Neuwirtova R, Ohyashiki K, Oscier D, Sanz G, Sanz M, Willman C. Greenberg P, et al. Among authors: sanz g, sanz m. J Clin Oncol. 2000 Oct 1;18(19):3447-52. doi: 10.1200/JCO.2000.18.19.3447. J Clin Oncol. 2000. PMID: 11013289 No abstract available.

6

Recent improvements in outcome for elderly patients with de novo acute myeloblastic leukemia.

López A, de la Rubia J, Martín G, Martínez J, Cervera J, Jarque I, Sempere A, Plumé G, Saavedra S, Regadera A, Sanz G, Gomis F, Pérez-Sirvent ML, Senent L, Jiménez C, Sanz MA. López A, et al. Among authors: sanz ma, sanz g. Leuk Res. 2001 Aug;25(8):685-92. doi: 10.1016/s0145-2126(01)00006-6. Leuk Res. 2001. PMID: 11397474

7

FLAG-IDA regimen (fludarabine, cytarabine, idarubicin and G-CSF) in the treatment of patients with high-risk myeloid malignancies.

de la Rubia J, Regadera A, Martín G, Cervera J, Sanz G, Martínez J, Jarque I, García I, Andreu R, Moscardó F, Jiménez C, Mollá S, Benlloch L, Sanz M. de la Rubia J, et al. Among authors: sanz g, sanz m. Leuk Res. 2002 Aug;26(8):725-30. doi: 10.1016/s0145-2126(02)00003-6. Leuk Res. 2002. PMID: 12191567 Clinical Trial.

8

Clinical application and proposal for modification of the International Working Group (IWG) response criteria in myelodysplasia.

Cheson BD, Greenberg PL, Bennett JM, Lowenberg B, Wijermans PW, Nimer SD, Pinto A, Beran M, de Witte TM, Stone RM, Mittelman M, Sanz GF, Gore SD, Schiffer CA, Kantarjian H. Cheson BD, et al. Blood. 2006 Jul 15;108(2):419-25. doi: 10.1182/blood-2005-10-4149. Epub 2006 Apr 11. Blood. 2006. PMID: 16609072 Free article.

9

The JAK2 V617F mutation identifies a subgroup of MDS patients with isolated deletion 5q and a proliferative bone marrow.

Ingram W, Lea NC, Cervera J, Germing U, Fenaux P, Cassinat B, Kiladjian JJ, Varkonyi J, Antunovic P, Westwood NB, Arno MJ, Mohamedali A, Gaken J, Kontou T, Czepulkowski BH, Twine NA, Tamaska J, Csomer J, Benedek S, Gattermann N, Zipperer E, Giagounidis A, Garcia-Casado Z, Sanz G, Mufti GJ. Ingram W, et al. Among authors: sanz g. Leukemia. 2006 Jul;20(7):1319-21. doi: 10.1038/sj.leu.2404215. Epub 2006 Apr 13. Leukemia. 2006. PMID: 16617322 No abstract available.

10

The JAK2 V617F mutation is rare in RARS but common in RARS-T.

Ceesay MM, Lea NC, Ingram W, Westwood NB, Gäken J, Mohamedali A, Cervera J, Germing U, Gattermann N, Giagounidis A, Garcia-Casado Z, Sanz G, Mufti GJ. Ceesay MM, et al. Among authors: sanz g. Leukemia. 2006 Nov;20(11):2060-1. doi: 10.1038/sj.leu.2404373. Epub 2006 Aug 24. Leukemia. 2006. PMID: 16932338 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

681 results

Search Page

Filters